CRT 2017 : DES BIOABSORBABLE & DCB TECHNOLOGIES - Biodegradable Polymer DES Programs

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

DES BIOABSORBABLE & DCB TECHNOLOGIES - Biodegradable Polymer DES Programs

Featuring

  • Robert Byrne
  • Dean Kereiakes
  • Stefan Verheye
  • Ron Waksman
  • Mitchell Krucoff
  • Ricardo Costa

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Does the Clinical Data Support the Use of DES With Biodegradable Polymers Over DES With Durable Polymers? - Robert Byrne
Micell MiStent: Novel Drug Delivery - Will It Improve Outcomes? - Dean Kereiakes
SYNERGY Stent Update: Clinical Trials, Registries and New Data on Stent Healing - Dean Kereiakes
EXCELLA Novolimus Elution From PLLA Polymer-Coated Stents - Stefan Verheye
Orsiro: PLLA/Sirolimus Biodegradable: The BIOFLOW Studies Moving Into the US - Ron Waksman
Combo: A Combination of Sirolimus-Eluting Biodegradable Polymer and Anti-CD34 Antibody Coated Stent - Mitchell Krucoff
Emerging Programs of DES with Biodegradable Polymers - Ricardo Costa

Target Audience

Learning Objectives

Related Moments

CRT 2016 Valve & Structural - Percutaneous Aortic Valves: Knowledge Gaps in a Maturing Technology
Conference
Percutaneous Aortic Valves: Knowledge Gaps in a Maturing Technology at CRT 2016
CRT 2016 Technology & Innovation - Japan FDA: Japan - US Synergies In The Second Decade - Opening Perspectives
Conference
A session explaining Japan - US Synergies In The Second Decade from CRT 2016
Twelve Months Dual Antiplatelet Therapy after Drug-eluting Stents – Too Long, too Short or Just Right?
Journal
Article on Twelve Months Dual Antiplatelet Therapy after Drug-eluting Stents – Too Long, too Short or Just Right?
Loading Simple Education